A Therapeutic Target for Smoking-Associated Lung Cancer

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Science Translational Medicine

• Publication date

  2010-12-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1126/scitranslmed.3001942PMID 21160076
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer.

  2010cited by this paper
• Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial.

  2010cited by this paper
• Potential for targeting the fibroblast growth factor receptors in breast cancer.

  2010cited by this paper
• Tumor heterogeneity is an active process maintained by a mutant EGFR-induced cytokine circuit in glioblastoma.

  2010cited by this paper
• Frequent and Focal FGFR1 Amplification Associates with Therapeutically Tractable FGFR1 Dependency in Squamous Cell Lung Cancer

  2010cited by this paper
• Preexistence and clonal selection of MET amplification in EGFR mutant NSCLC.

  2010cited by this paper
• Gefitinib or Carboplatin–Paclitaxel in Pulmonary Adenocarcinoma

  2010cited by this paper
• Array comparative genomic hybridization-based characterization of genetic alterations in pulmonary neuroendocrine tumors

  2010cited by this paper
• Fibroblast growth factor signalling: from development to cancer

  2010cited by this paper
• SOX2 Is an Amplified Lineage Survival Oncogene in Lung and Esophageal Squamous Cell Carcinomas

  2009cited by this paper
• F1000 highlights

  2009cited by this paper
• Lung adenocarcinoma with EGFR amplification has distinct clinicopathologic and molecular features in never-smokers.

  2009cited by this paper
• Fibroblast Growth Factor (FGF) and FGF Receptor-Mediated Autocrine Signaling in Non-Small-Cell Lung Cancer Cells

  2009cited by this paper
• Genomic imbalances in rhabdomyosarcoma cell lines affect expression of genes frequently altered in primary tumors: An approach to identify candidate genes involved in tumor development

  2009cited by this paper
• The fibroblast growth factor receptor inhibitor PD173074 blocks small cell lung cancer growth in vitro and in vivo.

  2009cited by this paper
• Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma.

  2009cited by this paper
• Assessment of a HER2 scoring system for gastric cancer: results from a validation study

  2008cited by this paper
• Fibroblast growth factor receptor-mediated signals contribute to the malignant phenotype of non-small cell lung cancer cells: therapeutic implications and synergism with epidermal growth factor receptor inhibition

  2008cited by this paper
• Recurrent FGFR1 amplification and high FGFR1 protein expression in oral squamous cell carcinoma (OSCC).

  2007cited by this paper
• High-Resolution Single Nucleotide Polymorphism Array Analysis of Epithelial Ovarian Cancer Reveals Numerous Microdeletions and Amplifications

  2007cited by this paper
• Monoclonal antibody antagonists of hypothalamic FGFR1 cause potent but reversible hypophagia and weight loss in rodents and monkeys.

  2007cited by this paper
• Identification of the transforming EML4–ALK fusion gene in non-small-cell lung cancer

  2007cited by this paper
• Inducible FGFR-1 activation leads to irreversible prostate adenocarcinoma and an epithelial-to-mesenchymal transition.

  2007cited by this paper
• FGF-2 protects small cell lung cancer cells from apoptosis through a complex involving PKCepsilon, B-Raf and S6K2.

  2006cited by this paper
• FGF‐2 protects small cell lung cancer cells from apoptosis through a complex involving PKCε, B‐Raf and S6K2

  2006cited by this paper
• Homozygous deletions and chromosome amplifications in human lung carcinomas revealed by single nucleotide polymorphism array analysis.

  2005cited by this paper
• Comprehensive Profiling of 8p11-12 Amplification in Breast Cancer

  2005cited by this paper
• High-resolution genomic profiles of human lung cancer.

  2005cited by this paper
• Inducible dimerization of FGFR1

  2002cited by this paper
• Soluble syndecan-1 and serum basic fibroblast growth factor are new prognostic factors in lung cancer.

  2002cited by this paper
• High pretreatment serum concentration of basic fibroblast growth factor is a predictor of poor prognosis in small cell lung cancer.

  2002cited by this paper
• BRAF and RAS mutations in human lung cancer and melanoma.

  2002cited by this paper
• Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.

  2001cited by this paper
• High-throughput tissue microarray analysis of 3p25 (RAF1) and 8p12 (FGFR1) copy number alterations in urinary bladder cancer.

  2001cited by this paper
• The n e w e n g l a n d j o u r n a l of m e d i c i n e

  2001cited by this paper
• Mapping of DNA amplifications at 15 chromosomal localizations in 1875 breast tumors: definition of phenotypic groups.

  1997cited by this paper

• An Integrative Analysis of Transcriptomics and Proteomics Reveals Novel Insights into the Response in the Midgut of Spodoptera frugiperda Larvae to Vip3Aa

  2022cites this paper
• Fibroblast Growth Factor Receptor, a Novel Receptor for Vegetative Insecticidal Protein Vip3Aa

  2018cites this paper
• 循环肿瘤细胞中不同表型细胞FGFR1基因表达程度与非小细胞肺癌临床病理特点相关性研究

  2018cites this paper
• High-Affinity Internalizing Human scFv-Fc Antibody for Targeting FGFR 1-overexpressing Lung Cancer Running Title : scFv-Fc for Targeting FGFR 1-positive Lung Cancer Cells

  2017cites this paper
• Oncogenic Characterization and Pharmacologic Sensitivity of Activating Fibroblast Growth Factor Receptor (FGFR) Genetic Alterations to the Selective FGFR Inhibitor Erdafitinib

  2017cites this paper
• Association of fibroblast growth factor receptor 1 gene amplification with poor survival in patients with esophageal squamous cell carcinoma

  2017cites this paper
• High-Affinity Internalizing Human scFv-Fc Antibody for Targeting FGFR1-Overexpressing Lung Cancer

  2017cites this paper
• A phase I, first in human study of FP-1039 (GSK3052230), a novel FGF ligand trap, in patients with advanced solid tumors.

  2016cites this paper
• A phase I , fi rst in human study of FP-1039 ( GSK 3052230 ) , a novel FGF ligand trap , in patients with advanced solid tumors

  2016cites this paper
• The frequency and impact of FGFR1 amplification on clinical outcomes in Korean patients with small cell lung cancer.

  2015cites this paper
• FAM83B is a novel biomarker for diagnosis and prognosis of lung squamous cell carcinoma

  2015cites this paper
• Lung and Mediastinal Tumors

  2015cites this paper
• Moving from histological subtyping to molecular characterization: new treatment opportunities in advanced non-small-cell lung cancer

  2014cites this paper
• FGFR1 amplification is associated with poor prognosis and smoking in non-small-cell lung cancer

  2014cites this paper
• Blockade of Nonhormonal Fibroblast Growth Factors by FP-1039 Inhibits Growth of Multiple Types of Cancer

  2013cites this paper
• Functional roles of fibroblast growth factor receptors (FGFRs) signaling in human cancers

  2013cites this paper
• Molecular pathology of lung cancer

  2013cites this paper
• Targeting Genomic Alterations in Squamous Cell Lung Cancer

  2013cites this paper
• Fibroblast growth factor receptor 1 gene amplification is associated with poor survival and cigarette smoking dosage in patients with resected squamous cell lung cancer.

  2013influential citation
• Advances towards the design and development of personalized non-small-cell lung cancer drug therapy

  2013cites this paper
• Genetic insight and therapeutic targets in squamous-cell lung cancer

  2012cites this paper
• Fibroblast growth factors and their receptors in cancer.

  2011cites this paper